Avita (ROCO:4735) Short-Term Debt: NT$252.4 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4735 Avita Corp ROCO:4735
69 GF Score
Price NT$39.00
GF Value NT$33.52
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Avita Short-Term Debt?

Avita ROCO:4735 -1.89% 69 Short-Term Debt is NT$252.4 Mil as of Jun. 2026. GuruFocus rates ROCO:4735 with a GF Score™ of 69/100 and a GF Value™ of NT$33.52 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Avita's Short-Term Debt for the quarter that ended in Jun. 2026 was NT$252.4 Mil.

Avita's quarterly Short-Term Debt increased from Dec. 2025 (NT$31.9 Mil) to Mar. 2026 (NT$120.5 Mil) and increased from Mar. 2026 (NT$120.5 Mil) to Jun. 2026 (NT$252.4 Mil).

Avita's annual Short-Term Debt declined from Dec. 2023 (NT$42.3 Mil) to Dec. 2024 (NT$14.8 Mil) but then increased from Dec. 2024 (NT$14.8 Mil) to Dec. 2025 (NT$31.9 Mil).


Avita Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Avita Short-Term Debt Related Terms


Avita Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Avita's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avita Short-Term Debt Chart

Avita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 288.78 72.39 42.26 14.75 31.89

Avita Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.88 10.50 31.89 120.49 252.41
ROCO:4735
69GF Score
Avita Corp ROCO:4735
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of NT$252.4 Mil mean?
Avita (ROCO:4735) has a Short-Term Debt of NT$252.4 Mil as of Jun. 2026.
Is Avita's Short-Term Debt too high?
Avita's current Short-Term Debt is NT$252.4 Mil. Overall, Avita has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avita's Short-Term Debt compare to ABT and SYK?
Avita's Short-Term Debt of NT$252.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Avita's current Short-Term Debt is NT$252.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avita stock overvalued right now?
Based on GuruFocus' analysis, Avita (ROCO:4735) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$33.52, compared to a current price of NT$39.00 — trading 16.3% above its estimated fair value. The current Short-Term Debt is NT$252.4 Mil. Avita's overall GF Score™ is 69/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Avita (ROCO:4735), the current Short-Term Debt is NT$252.4 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avita (ROCO:4735) Overvalued in 2026?

Based on GuruFocus' analysis, Avita stock appears to be overvalued. The current stock price of NT$39.00 is trading 16.3% above its estimated GF Value™ of NT$33.52. GuruFocus considers Avita to be Modestly Overvalued.

Key valuation signals for ROCO:4735:

  • Short-Term Debt: NT$252.4 Mil
  • GF Value™: NT$33.52 vs. price of NT$39.00 (16.3% above fair value)
  • GF Score™: 69/100 with 10 warning signs

No single metric tells the full story. See the ROCO:4735 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Avita Business Description

Address No.78, Sec.1, Guangfu road, 9th floor, Sanchong district, New Taipei City, TWN, 24158
Avita Corp is a manufacturer of point-of-care health products designed for clinical and personal use. The company provides body composition analyzers, blood pressure monitors, blood glucose monitors, digital thermometers, and nasal care devices. Its products include a thermometer, nasal aspirator, blood pressure monitor arm, and wrist.
69GF Score

Get the complete analysis for ROCO:4735

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$39.00
Price
NT$33.52
GF Value